(-)SCOPOLAMINE N-BUTYL BROMIDE (C005B-351540)

Catalog No.: C005B-351540
Mfr. No.: S7882-5G
Mfr. Name: Sigma-Aldrich
Qty/UOM: 5
UOM: GM

Price: $349.98

List Price: $388.86

Application (−:)-Scopolamine N-butyl bromide was used as standard in designing a procedure for quantification of compounds using CE-MS. 8 Biochem/physiol Actions Competitive muscarinic acetylcholine receptor antagonist: antispasmodic.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Application

(−)-Scopolamine N-butyl bromide was used as standard in designing a procedure for quantification of compounds using CE-MS.⁸

Biochem/physiol Actions

Competitive muscarinic acetylcholine receptor antagonist; antispasmodic.

Scopolamine is an anti-muscarinic and cholinolytic alkaloid that inhibits parasympathetic-cholinergic system.⁵ The central effects include hallucinations, disorientation, restlessness and euphoria.⁶ Scopolamine disturb the stimulus detection performance in rats by interfering with the reticular cholinergic pathways.⁷

UPC:: 51151500
Condition:: New
Availability:: 3-5 Days
Weight:: 1.00 Ounces
HazmatClass:: No
MPN:: S7882-5G
CAS:: 149-64-4

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."